ECM Weekly (4th July 2021) - Xpeng, Medbot, Medlive, Brii Bio, CTOS, LinkDoc, Devyani, Manycore
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
697 Views
Softbank Group - Vision Fundās Public Companies on Wild Ride to End Quarter in the Black
Vision Fund's portfolio moved into the black for Q1 thanks to IPOs and some amazing qtr-end moves by a few VF stocks. Report includes updated...
401 Views
Weekly Innovation Review (WIRE) #38
Headline Developments: We can now modify DNA inside of a human body (in vivo), thanks to some groundbreaking work announced this week
397 Views
DiDi Global IPO: Trading Debut
Didi has priced its IPO at $14 per ADS and sold 10% more ADSs than planned. Our relative valuation and SoTP valuation suggests a full price. We...
413 Views
Didi Chuxing (DIDI US): Avoid Buyers' Remorse - Do an Apples to Apples Comparison
DiDi IPO raised USD4.4 bn today, pricing at the top of its indicated range and selling more shares than initially planned. I offer three reasons...
585 Views